IS5902A - Notkun á asýlkarnitínum sem miðlum gegn æxli - Google Patents

Notkun á asýlkarnitínum sem miðlum gegn æxli

Info

Publication number
IS5902A
IS5902A IS5902A IS5902A IS5902A IS 5902 A IS5902 A IS 5902A IS 5902 A IS5902 A IS 5902A IS 5902 A IS5902 A IS 5902A IS 5902 A IS5902 A IS 5902A
Authority
IS
Iceland
Prior art keywords
tumor suppressor
acyl carnitine
carnitine
acyl
somatosstatin
Prior art date
Application number
IS5902A
Other languages
English (en)
Inventor
Scandurra Laura
Maria Stivala Franca
Allegra Eugenia
Rapisarda Grazia
Original Assignee
Università degli Studi di Catania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Università degli Studi di Catania filed Critical Università degli Studi di Catania
Publication of IS5902A publication Critical patent/IS5902A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
IS5902A 1998-09-30 2001-03-20 Notkun á asýlkarnitínum sem miðlum gegn æxli IS5902A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI002090A IT1302289B1 (it) 1998-09-30 1998-09-30 Composizioni farmaceutiche ad attivita' antineoplastica
PCT/EP1999/007170 WO2000018385A2 (en) 1998-09-30 1999-09-27 Use of acylcarnitines as antitumour agents

Publications (1)

Publication Number Publication Date
IS5902A true IS5902A (is) 2001-03-20

Family

ID=11380776

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5902A IS5902A (is) 1998-09-30 2001-03-20 Notkun á asýlkarnitínum sem miðlum gegn æxli

Country Status (16)

Country Link
US (1) US6673839B1 (is)
EP (1) EP1117393B1 (is)
JP (1) JP2002525316A (is)
AT (1) ATE358476T1 (is)
AU (1) AU761357B2 (is)
CA (1) CA2345724C (is)
DE (1) DE69935724T2 (is)
DK (1) DK1117393T3 (is)
ES (1) ES2284267T3 (is)
IL (1) IL142295A (is)
IS (1) IS5902A (is)
IT (1) IT1302289B1 (is)
NO (1) NO20011578L (is)
NZ (1) NZ510803A (is)
WO (1) WO2000018385A2 (is)
ZA (1) ZA200102545B (is)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006347935A (ja) * 2005-06-15 2006-12-28 Masanori Ogata 炎症性サイトカインの産生が関与する疾患の予防及び/又は治療のための医薬
EA018442B1 (ru) * 2007-03-21 2013-08-30 Сигма-Тау Индустрие Фармасьютике Риуните С.П.А. Применение l-карнитина для лечения гипертензии, для снижения систолического или пульсового давления крови у субъектов с предиабетом
EA201170732A1 (ru) * 2008-12-01 2011-12-30 Сигма-Тау Индустрие Фармасьютике Риуните С.П.А. Применение алканоил l-карнитина в комбинации с химиотерапевтическими средствами для лечения новообразований

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05339148A (ja) 1992-05-28 1993-12-21 T Knight Albert 血液脳関門を通過する物質
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
IT1277898B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso di amminoacidi basici, di acil derivati di amminoacidi basici e di loro sali farmaceuticamente accettabili per la profilassi di malattie
WO1997006788A1 (en) * 1995-08-14 1997-02-27 Janssen Pharmaceutica N.V. Transdermal administration of vorozole
JPH11292787A (ja) 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
IT1283951B1 (it) * 1996-03-15 1998-05-07 Mendes Srl Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
DE69923322T2 (de) * 1998-07-30 2005-12-22 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Verwendung von propionyl-l-carnitin und acetyl-l-carnitin zur herstellung von arzneimittel mit antikrebs wirkung

Also Published As

Publication number Publication date
AU761357B2 (en) 2003-06-05
ZA200102545B (en) 2001-09-28
WO2000018385A2 (en) 2000-04-06
JP2002525316A (ja) 2002-08-13
NO20011578L (no) 2001-05-30
IL142295A (en) 2004-08-31
NZ510803A (en) 2003-08-29
IL142295A0 (en) 2002-03-10
WO2000018385A3 (en) 2000-05-25
EP1117393B1 (en) 2007-04-04
ATE358476T1 (de) 2007-04-15
NO20011578D0 (no) 2001-03-28
IT1302289B1 (it) 2000-09-05
CA2345724A1 (en) 2000-04-06
EP1117393A2 (en) 2001-07-25
US6673839B1 (en) 2004-01-06
ITMI982090A1 (it) 2000-03-30
DK1117393T3 (da) 2007-08-06
AU6087799A (en) 2000-04-17
CA2345724C (en) 2009-05-19
ES2284267T3 (es) 2007-11-01
DE69935724T2 (de) 2007-12-27
DE69935724D1 (en) 2007-05-16

Similar Documents

Publication Publication Date Title
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
HRP20030383B1 (hr) Laktamski spoj
TR199902400T2 (xx) Fungusit etkinlik g�steren terkiplerin birle�imleri.
PT1109812E (pt) Pirrolobenzodiazepinas
AP2002002637A0 (en) Novel piperazine
DK1297013T3 (da) Anvendelse af TACI som antitumormiddel
HRP20010117B1 (en) Novel salt form of pantoprazole
BR0116217A (pt) Quinolonas antimicrobianas, composição farmacêutica, bem como aplicação farmacêutica das referidas quinolonas
ES2191208T3 (es) Oxiimino-pregnano-carbolactonas.
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
ES2187261B2 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
SE9901077D0 (sv) Novel use
EA200300450A1 (ru) Фармацевтические растворы соединений модафинила
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
BR0007922A (pt) Compostos calcilìticos
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
TR200002203T2 (tr) Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi.
EA200200948A1 (ru) Лечение псориаза
ES2052105T3 (es) Gilanteno: principio anti-metastasico de sanguijuela de america del sur haementaria ghilianii.
NO20011578L (no) Anvendelse av acylkarnitiner som antitumormidler
ES2157419T3 (es) Arilazadioxacicloalquenos substituidos, fungicidas.
ATE249204T1 (de) Spray, enthaltend ubichinon qn
PL369295A1 (en) Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
EA200400382A1 (ru) Применение специфической дозы фондапаринукса натрия для лечения окс